No profile data available.
Intelligent Bio Solutions Inc. (INBS) is a healthcare company in the chemical laboratory testing equipment industry, based in New York, United States, with about 59 full-time employees.
It reported revenue of $4.22 million for fiscal year 2026, up 38.1% from fiscal year 2025, and net income of -$12.43 million. Its largest business segment, United Kingdom, brought in 99% of segment revenue in fiscal year 2026; Other Country was the largest region with 65%. Its market capitalization was $5.07 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended June 30, 2026; market data as of October 9, 2026.
, a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform.
Intelligent Bio Solutions reported $4.22 million in revenue for fiscal year 2026, up 38.1% from $3.05 million in fiscal year 2025.
United Kingdom, with $4.15 million or 99% of segment revenue in fiscal year 2026. Next: Rest of World (1%) and Asia Pacific (under 1%).
Other Country: 65% of revenue by region in fiscal year 2026, followed by Asia Pacific (20%).
$5.07 million as of October 9, 2026.
Listed companies of a similar size in the same industry (chemical laboratory testing equipment) include OraSure Technologies, Inc. (OSUR), Anbio Biotechnology (NNNN), DarioHealth Corp. (DRIO), Bluejay Diagnostics, Inc. (BJDX).